Merck earnings top estimates amid solid demand for Keytruda cancer drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. LEN
7. APO
8. TLT
9. BETR
10. AMZN

Go back to Merck earnings top estimates amid solid demand for Keytruda cancer drug
Merck & Co. (NYSE: MRK) Delayed: 147.25 +2.34 (1.61%)
Previous Close $144.91    52 Week High $65.46 
Open $145.74    52 Week Low $47.97 
Day High $147.40    P/E 100.17 
Day Low $145.32    EPS $1.47 
Volume 1,886,240